Literature DB >> 6874066

Enhancement of dengue virus type 2 replication in mouse macrophage cultures by bacterial cell walls, peptidoglycans, and a polymer of peptidoglycan subunits.

H Hotta, S Hotta, H Takada, S Kotani, S Tanaka, M Ohki.   

Abstract

The effects of bacterial cell walls, peptidoglycans, and a water-soluble polymer of peptidoglycan subunits on dengue virus type 2 replication in cultured mouse peritoneal macrophages were studied. Pretreatment of macrophage cultures with all of test cell walls isolated from seven bacterial species for 3 days significantly enhanced the virus production in the cultures. Peptidoglycans prepared from four of the above cell walls also exerted the virus production-enhancing effects in a similar manner as the walls. A water-soluble polymer of peptidoglycan subunits which was prepared by treatment of Staphylococcus epidermidis wall peptidoglycan with an interpeptide bridge-splitting enzyme (endopeptidase) also definitely enhanced the virus production in macrophage cultures, although its activity was weaker than that of the original wall and peptidoglycan. Macrophage cultures from athymic nude mice, when treated with cell walls and peptidoglycans of S. epidermidis and Lactobacillus plantarum for 3 days, also showed an increased ability to support dengue virus type 2 replication. The infectious center assay demonstrated that the virus replication enhancement by S. epidermidis cell wall and peptidoglycan was primarily due to an increase in the number of virus-infected cells. This finding did not seem to be in conflict with the observation that macrophages treated with the above cell wall or peptidoglycan phagocytized more latex particles than did untreated macrophages. The conclusions based on the above experiments are that the treatment of mouse peritoneal macrophage cultures with bacterial cell walls and their components increases the take of dengue virus type 2 by macrophages and thus raises the virus production in the macrophage cultures.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874066      PMCID: PMC264663          DOI: 10.1128/iai.41.2.462-469.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Gelation of the amoebocyte lysate of Tachypleus tridentatus by cell wall digest of several gram-positive bacteria and synthetic peptidoglycan subunits of natural and unnatural configurations.

Authors:  S Kotani; Y Watanabe; F Kinoshita; K Kato; K Harada
Journal:  Biken J       Date:  1977-03

Review 2.  Peptidoglycan types of bacterial cell walls and their taxonomic implications.

Authors:  K H Schleifer; O Kandler
Journal:  Bacteriol Rev       Date:  1972-12

3.  The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells.

Authors:  R van Furth; Z A Cohn; J G Hirsch; J H Humphrey; W G Spector; H L Langevoort
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

4.  Research on dengue in tissue culture. I. Plaque formation in an established monkey kidney cell line culture.

Authors:  S Hotta; N Fujita; T Maruyama
Journal:  Kobe J Med Sci       Date:  1966-09

5.  Inhibition of macrophage migration by synthetic muramyl dipeptide.

Authors:  Y Yamamoto; S Nagao; A Tanaka; T Koga; K Onoue
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

6.  Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants.

Authors:  D Juy; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

7.  Spectrum and possible mechanism of carrageenan cytotoxicity.

Authors:  P J Catanzaro; H J Schwartz; R C Graham
Journal:  Am J Pathol       Date:  1971-08       Impact factor: 4.307

8.  Immunological and biophysical separation of dengue-2 antigens.

Authors:  R D Cardiff; W E Brandt; T G McCloud; D Shapiro; P K Russell
Journal:  J Virol       Date:  1971-01       Impact factor: 5.103

9.  Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody.

Authors:  S B Halstead; E J O'Rourke
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

10.  Dengue viruses and mononuclear phagocytes. II. Identity of blood and tissue leukocytes supporting in vitro infection.

Authors:  S B Halstead; E J O'Rourke; A C Allison
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  5 in total

1.  Smp76, a Scorpine-Like Peptide Isolated from the Venom of the Scorpion Scorpio maurus palmatus, with a Potent Antiviral Activity Against Hepatitis C Virus and Dengue Virus.

Authors:  Alaa M H El-Bitar; Moustafa Sarhan; Mohamed A Abdel-Rahman; Veronica Quintero-Hernandez; Chie Aoki-Utsubo; Mohsen A Moustafa; Lourival D Possani; Hak Hotta
Journal:  Int J Pept Res Ther       Date:  2019-07-06       Impact factor: 1.931

2.  Lectin-mediated enhancement of dengue virus infection in a mouse macrophage cell line Mk1.

Authors:  H Hotta; M Homma
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

3.  Virocidal activity of Egyptian scorpion venoms against hepatitis C virus.

Authors:  Alaa M H El-Bitar; Moustafa M H Sarhan; Chie Aoki; Yusuke Takahara; Mari Komoto; Lin Deng; Mohsen A Moustafa; Hak Hotta
Journal:  Virol J       Date:  2015-03-24       Impact factor: 4.099

4.  Broad-spectrum antiviral agents: secreted phospholipase A2 targets viral envelope lipid bilayers derived from the endoplasmic reticulum membrane.

Authors:  Ming Chen; Chie Aoki-Utsubo; Masanori Kameoka; Lin Deng; Yutaka Terada; Wataru Kamitani; Kei Sato; Yoshio Koyanagi; Makoto Hijikata; Keiko Shindo; Takeshi Noda; Michinori Kohara; Hak Hotta
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

5.  A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies.

Authors:  T Hohdatsu; M Nakamura; Y Ishizuka; H Yamada; H Koyama
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.